Trial Profile

A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 22 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

15 Apr 2022 Results of post-hoc analysis assessing the potential impact of sex and body mass index (BMI) on response in the SEAM-PsA trial, published in The Journal of Rheumatology.
30 Aug 2020 Results comparing the performance of composite measures published in the Rheumatology.
06 Jun 2020 Results assessing influence of sex and BMI at 24-week outcomes in a 48-wk PsA, presented at the 21st Annual Congress of the European League Against Rheumatism.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com